Viemed Healthcare, INC 8-K filings

Viemed Healthcare announced record net revenues of $78.1 million for the second quarter of 2026, driven by significant growth in ventilator and PAP therapy patients, and has raised its full-year revenue guidance.

Viemed Healthcare's shareholders approved a second amendment to its 2024 Long Term Incentive Plan, increasing the share reserve and ratified the appointment of Ernst & Young LLP as auditors.

Viemed Healthcare Inc. presented its investor deck for June 2026, highlighting robust financial performance, strategic expansion into new service lines, and a strong outlook driven by industry tailwinds.

Viemed Healthcare reports strong Q1 2026 results with 28% revenue growth and updated full-year guidance, driven by diversification and capital efficiency.

Viemed Healthcare, Inc. highlights record 2025 financial results and provides robust 2026 guidance, driven by diversified home-based clinical care services and strategic growth initiatives.

Viemed Healthcare reported record financial results for 2025, driven by strong organic growth and acquisitions, and announced a new share repurchase program.

Viemed Healthcare, Inc. extended its delayed draw term loan commitment to November 29, 2026, and highlighted robust Q3 2025 financial and operational performance, driven by growth in sleep therapy and strategic acquisitions.

Viemed Healthcare, Inc. announced record third-quarter 2025 financial results, driven by strong patient growth and strategic acquisition, while updating its full-year guidance.

Viemed Healthcare, Inc. announced the successful completion of its previously authorized share repurchase program, buying back 1,976,441 common shares for approximately $13.2 million.

Viemed Healthcare, a leading in-home clinical care provider, announced record second quarter 2025 financial results, driven by strong revenue growth and patient count increases, and raised its full-year guidance.

Viemed Healthcare, Inc. has completed its previously announced acquisition of Lehans Medical Equipment for a base price of $26 million plus contingent consideration, and expects to update its full-year 2025 guidance to reflect the acquisition's contribution.

Viemed Healthcare, Inc. announced a new share repurchase program of up to 1.98 million common shares and increased its 2025 financial guidance, signaling strong operational performance and a commitment to shareholder value.

Viemed Healthcare, Inc. announced that its shareholders approved all proposals at the Annual General and Special Meeting, including an amendment to the 2024 Long Term Incentive Plan, director re-elections, and auditor appointment.

Viemed Healthcare announces a 17% increase in Q1 2025 revenue, driven by growth in ventilator and PAP therapy patient counts, and updates its full-year guidance while also announcing an agreement to acquire Lehans Medical Equipment.

Viemed Healthcare announces a definitive agreement to acquire Lehan Drugs, Inc., a home medical equipment provider, for a base purchase price of $26 million, diversifying its product mix into maternal health.

Bruce Greenstein resigned from Viemed Healthcare's Board of Directors, effective immediately, with no indication of disagreement with the company.

Viemed Healthcare Inc. reports record net revenues and adjusted EBITDA for 2024, projecting continued growth into 2025 with strategic initiatives and market expansion.

Viemed Healthcare reports record 2024 revenues and provides guidance for continued growth in 2025.

Viemed Healthcare's investor presentation outlines its position as a leading provider of home respiratory care, emphasizing growth, market expansion, and strategic acquisitions.

Viemed Healthcare announced record net revenues of $58.0 million for the third quarter of 2024, a 17.4% increase year-over-year, alongside a 33% increase in net income.

Viemed Healthcare, a leading provider of home respiratory care, outlines its growth strategy and market position in a new investor presentation.

Viemed Healthcare announced record second-quarter 2024 financial results, with net revenues reaching $55.0 million, a 27% increase year-over-year.

Viemed Healthcare's shareholders approved the 2024 Long-Term Incentive Plan and elected eight directors at the Annual & Special Meeting on June 6, 2024.

Viemed Healthcare has amended its credit agreement, extending the deadline for its delayed draw term loan commitment to November 29, 2025.

Viemed Healthcare, a leading provider of home respiratory care, presented its growth strategy and market position to investors, highlighting its expansion in the home medical equipment market and its focus on non-invasive ventilation.

Viemed Healthcare announced a 28% increase in net revenue and a 21% increase in adjusted EBITDA for the first quarter of 2024, demonstrating strong growth and operational improvements.

Viemed Healthcare has finalized a strategic partnership with East Alabama Health, acquiring a controlling interest in East Alabama HomeMed, LLC.

Viemed Healthcare, a leading provider of in-home respiratory care, released an investor presentation detailing its market position, growth strategy, and financial performance.

Viemed Healthcare reported record annual revenue and net income for 2023, driven by strong growth in its respiratory care and home medical equipment services.